Failure of Perivascular Drainage of -amyloid in Cerebral Amyloid Angiopathy

被引:120
|
作者
Hawkes, Cheryl A. [1 ]
Jayakody, Nimeshi [1 ]
Johnston, David A. [1 ]
Bechmann, Ingo [2 ]
Carare, Roxana O. [1 ]
机构
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany
基金
英国生物技术与生命科学研究理事会;
关键词
Alzheimer's disease; amyloid; cerebral amyloid angiopathy; interstitial fluid neuroimmunology; perivascular drainage; CONVECTION-ENHANCED DELIVERY; INTERSTITIAL FLUID DRAINAGE; BETA FIBRIL FORMATION; ALZHEIMERS-DISEASE; A-BETA; APOLIPOPROTEIN-E; BASEMENT-MEMBRANES; TRANSFORMING GROWTH-FACTOR-BETA-1; CEREBROVASCULAR PATHOLOGY; SCAVENGER RECEPTOR;
D O I
10.1111/bpa.12159
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Alzheimer's disease, amyloid- (A) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of A in the walls of capillaries and arteries in CAA suggests that A is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble A from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including A. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of A. The failure of perivascular clearance of A may be a major factor in the accumulation of A in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 50 条
  • [21] Cerebral amyloid angiopathy
    Block, F.
    NERVENARZT, 2011, 82 (02): : 202 - 206
  • [22] CEREBRAL AMYLOID ANGIOPATHY
    MIRSEN, T
    HACHINSKI, V
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (16): : 2248 - 2248
  • [23] Cerebral Amyloid Angiopathy
    Yamada, Masahito
    Naiki, Hironobu
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 41 - 78
  • [24] CEREBRAL AMYLOID ANGIOPATHY
    DUBAS, F
    PRESSE MEDICALE, 1994, 23 (20): : 948 - 950
  • [25] Cerebral amyloid angiopathy
    Kalashnikova, L. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (09): : 86 - +
  • [26] Cerebral amyloid angiopathy
    Laly, Florian
    Duveau, Jean-Paul
    Behar, Federic
    Veysseyre, Anne-Marie
    Palisson, Muriel
    PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT, 2007, 5 (01): : 35 - 45
  • [27] CEREBRAL AMYLOID ANGIOPATHY
    MIKOL, J
    WOIMANT, F
    HAGUENAU, M
    ANNALES DE MEDECINE INTERNE, 1995, 146 (03): : 166 - 173
  • [28] CEREBRAL AMYLOID ANGIOPATHY
    LEBLANC, R
    COSGROVE, RG
    MEAGHERVILLEMURE, K
    ETHIER, R
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (02) : 328 - 329
  • [29] Cerebral Amyloid Angiopathy
    Greenberg, Steven M.
    van Veluw, Susanne J.
    STROKE, 2024, 55 (05) : 1409 - 1411
  • [30] CEREBRAL AMYLOID ANGIOPATHY
    COSGROVE, GR
    LEBLANC, R
    MEAGHERVILLEMURE, K
    ETHIER, R
    NEUROLOGY, 1985, 35 (05) : 625 - 631